NanoViricides Earnings Estimate

NNVC Stock  USD 0.93  0.08  7.92%   
By analyzing NanoViricides' earnings estimates, investors can diagnose different trends across NanoViricides' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for NanoViricides is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
NanoViricides is projected to generate -0.0875 in earnings per share on the 30th of June 2026. NanoViricides earnings estimates show analyst consensus about projected NanoViricides EPS (Earning Per Share). It derives the highest and the lowest estimates based on NanoViricides' historical volatility. Many public companies, such as NanoViricides, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing NanoViricides' earnings estimates, investors can diagnose different trends across NanoViricides' analyst sentiment over time as well as compare current estimates against different timeframes. As of February 13, 2026, Gross Profit is expected to decline to about (702.9 K)Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.

NanoViricides Earnings per Share Projection vs Actual

About NanoViricides Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of NanoViricides earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current NanoViricides estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as NanoViricides fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-134 M-127.3 M
Retained Earnings Total Equity-95 M-90.3 M
Earnings Yield(0.51)(0.49)
Price Earnings Ratio(2.01)(2.11)
Price Earnings To Growth Ratio 0.26  0.24 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether NanoViricides offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NanoViricides' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nanoviricides Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nanoviricides Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Will Biotechnology sector continue expanding? Could NanoViricides diversify its offerings? Factors like these will boost the valuation of NanoViricides. Anticipated expansion of NanoViricides directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every NanoViricides data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.50)
Return On Assets
(0.51)
Return On Equity
(0.94)
Understanding NanoViricides requires distinguishing between market price and book value, where the latter reflects NanoViricides's accounting equity. The concept of intrinsic value - what NanoViricides' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push NanoViricides' price substantially above or below its fundamental value.
It's important to distinguish between NanoViricides' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NanoViricides should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, NanoViricides' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.